News | April 07, 2015

United Kingdom to Receive First Three Proton Beam Therapy Centers

First center will be operational in 2016, remaining two by 2017

UK, United Kingdom, proton beam therapy centers, Proton Partners International

April 7, 2015 — The United Kingdom is to get its first three proton beam therapy centers, marking a significant breakthrough in the provision of cancer treatment. Cardiff-based Proton Partners International Ltd is to open the treatment centers in Cardiff, London and Northumberland by 2017; the first - Cardiff - will be operational next year. The centers will be available for National Health Service (NHS) patients from England, Scotland and Wales, medically-insured private patients and self-paying patients.

Proton Partners International was formed following discussions between Prof. Sir Chris Evans, the leading life sciences entrepreneur, and leading U.K. life sciences and healthcare investors on addressing cancer treatment in the United Kingdom. Institutional and private investors have committed to almost £100m equity finance in the company.

Prof. Gordon McVie, senior consultant at the European Institute of Oncology, has been appointed chairman, and Prof. Karol Sikora has agreed to become chief medical adviser to the company, alongside a range of renowned cancer and healthcare experts.

McVie said: "This is an exciting and important development of the provision of cancer treatment in the U.K. As things stand, patients who can benefit from this treatment have to go abroad for treatment, often at great expense to the NHS. The creation of these centers will go a long way to ensuring the very best of treatment is available in the U.K."

Sikora said: "I was delighted to be approached by Sir Chris as there are only 40 proton beam therapy centers around the world and a pressing need for more. In the U.K. there are none. Given the aging population, there will be a significant rise in the number of cancer cases in the U.K., and therefore we should do what is necessary to provide the appropriate level and type of care."

Evans and his team at Arthurian Life Sciences, which manages the £100 million Wales Life Sciences Investment Fund established by the Welsh Government, are investing in the company through the fund.

In addition to state-of-the-art Proton Partners' treatment services, the Cardiff center will provide conventional radiotherapy, chemotherapy and supportive care. This could then be offered through other centers.

In the future, Proton Partners International intends to develop further proton therapy centers in Asia, the Middle East and Africa.

The government has announced that it will create two NHS proton beam therapy units, which will open in 2018.

For more information: www.nhs.uk

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...